A risk score for predicting death in COVID-19 in-hospital infection: A Brazilian single-center study.
COVID-19
in-hospital patients
mortality
Journal
Journal of clinical ultrasound : JCU
ISSN: 1097-0096
Titre abrégé: J Clin Ultrasound
Pays: United States
ID NLM: 0401663
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
revised:
17
01
2022
received:
08
11
2021
accepted:
16
02
2022
pubmed:
1
4
2022
medline:
10
6
2022
entrez:
31
3
2022
Statut:
ppublish
Résumé
There is a paucity of information about Brazilian COVID-19 in-hospital mortality probability of death combining risk factors. We aimed to correlate COVID-19 Brazilian in-hospital patients' mortality to demographic aspects, biomarkers, tomographic, echocardiographic findings, and clinical events. A prospective study, single tertiary center in Brazil, consecutive patients hospitalized with COVID-19. We analyzed the data from 111 patients from March to August 2020, performed a complete transthoracic echocardiogram, chest thoracic tomographic (CT) studies, collected biomarkers and correlated to in-hospital mortality. Mean age of the patients: 67 ± 17 years old, 65 (58.5%) men, 29 (26%) presented with systemic arterial hypertension, 18 (16%) with diabetes, 11 (9.9%) with chronic obstructive pulmonary disease. There was need for intubation and mechanical ventilation of 48 (43%) patients, death occurred in 21/111 (18.9%) patients. Multiple logistic regression models correlated variables with mortality: age (OR: 1.07; 95% CI 1.02-1.12; p: 0.012; age >74 YO AUC ROC curve: 0.725), intubation need (OR: 23.35; 95% CI 4.39-124.36; p < 0.001), D dimer (OR: 1.39; 95% CI 1.02-1.89; p: 0.036; value >1928.5 ug/L AUC ROC curve: 0.731), C-reactive protein (OR: 1.18; 95% CI 1.05-1.32; p < 0.005; value >29.35 mg/dl AUC ROC curve: 0.836). A risk score was created to predict intrahospital probability of death, by the equation: 3.6 (age >75 YO) + 66 (intubation need) + 28 (C-reactive protein >29) + 2.2 (D dimer >1900). A novel and original risk score were developed to predict the probability of death in Covid 19 in-hospital patients concerning combined risk factors.
Sections du résumé
BACKGROUND
BACKGROUND
There is a paucity of information about Brazilian COVID-19 in-hospital mortality probability of death combining risk factors.
OBJECTIVE
OBJECTIVE
We aimed to correlate COVID-19 Brazilian in-hospital patients' mortality to demographic aspects, biomarkers, tomographic, echocardiographic findings, and clinical events.
METHODS
METHODS
A prospective study, single tertiary center in Brazil, consecutive patients hospitalized with COVID-19. We analyzed the data from 111 patients from March to August 2020, performed a complete transthoracic echocardiogram, chest thoracic tomographic (CT) studies, collected biomarkers and correlated to in-hospital mortality.
RESULTS
RESULTS
Mean age of the patients: 67 ± 17 years old, 65 (58.5%) men, 29 (26%) presented with systemic arterial hypertension, 18 (16%) with diabetes, 11 (9.9%) with chronic obstructive pulmonary disease. There was need for intubation and mechanical ventilation of 48 (43%) patients, death occurred in 21/111 (18.9%) patients. Multiple logistic regression models correlated variables with mortality: age (OR: 1.07; 95% CI 1.02-1.12; p: 0.012; age >74 YO AUC ROC curve: 0.725), intubation need (OR: 23.35; 95% CI 4.39-124.36; p < 0.001), D dimer (OR: 1.39; 95% CI 1.02-1.89; p: 0.036; value >1928.5 ug/L AUC ROC curve: 0.731), C-reactive protein (OR: 1.18; 95% CI 1.05-1.32; p < 0.005; value >29.35 mg/dl AUC ROC curve: 0.836). A risk score was created to predict intrahospital probability of death, by the equation: 3.6 (age >75 YO) + 66 (intubation need) + 28 (C-reactive protein >29) + 2.2 (D dimer >1900).
CONCLUSIONS
CONCLUSIONS
A novel and original risk score were developed to predict the probability of death in Covid 19 in-hospital patients concerning combined risk factors.
Identifiants
pubmed: 35355290
doi: 10.1002/jcu.23195
pmc: PMC9088307
doi:
Substances chimiques
Biomarkers
0
C-Reactive Protein
9007-41-4
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
604-610Informations de copyright
© 2022 Wiley Periodicals LLC.
Références
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
Lancet. 2020 Feb 15;395(10223):470-473
pubmed: 31986257
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
J Biol Regul Homeost Agents. 2019 Feb 4;34(1):9-14
pubmed: 32013309
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Radiology. 2020 Aug;296(2):E46-E54
pubmed: 32155105
J Biol Regul Homeost Agents. 2020 Mar 14;34(2):327-331
pubmed: 32171193
Semin Immunopathol. 2017 Jul;39(5):529-539
pubmed: 28466096
Lancet Respir Med. 2020 Apr;8(4):e21
pubmed: 32171062
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Eur Heart J. 2020 Jun 7;41(22):2070-2079
pubmed: 32391877
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
N Engl J Med. 2009 Apr 9;360(15):1526-38
pubmed: 19357408
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Eur Heart J Cardiovasc Imaging. 2015 Mar;16(3):233-70
pubmed: 25712077
J Am Coll Cardiol. 2020 Jun 23;75(24):3078-3084
pubmed: 32272153
Lancet. 2020 Feb 29;395(10225):689-697
pubmed: 32014114
Radiol Cardiothorac Imaging. 2020 Feb 13;2(1):e200034
pubmed: 33778547
Circulation. 2020 Jul 28;142(4):342-353
pubmed: 32469253
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
JACC Cardiovasc Imaging. 2020 Nov;13(11):2287-2299
pubmed: 32654963
J Clin Ultrasound. 2022 Jun;50(5):604-610
pubmed: 35355290
Rev Esp Cardiol (Engl Ed). 2021 Jan;74(1):24-32
pubmed: 33144126
N Engl J Med. 2020 Mar 5;382(10):970-971
pubmed: 32003551
BMC Med. 2020 Feb 28;18(1):57
pubmed: 32106852
Eur Heart J. 2013 Sep;34(33):2636-48, 2648a-2648d
pubmed: 23824828